Statistics
Publications
16
Citations
1.4K
H-Index
13
Active since
1998
Bérengère Sauvagnat is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, chemistry, and pharmacy.
Publications per year
1998–2023
16
16
An orally available non-nucleotide STING agonist with antitumor activity
Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 660 citations
Nanoscale synthesis and affinity ranking
Nathan J. Gesmundo, Bérengère Sauvagnat, Patrick J. Curran et al. · Nature · 2018 · 214 citations
1–5 of 16